Cargando…
The efficacy and safety of nirsevimab for the prevention of RSV infection among infants: A systematic review and meta-analysis
BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of morbidity and mortality among infants with a global incidence of 9.5% and a mortality rate of 2.2%. The management of RSV infection is mainly supportive and, aside from emerging monoclonal antibodies, there has been no benefit of mo...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110918/ https://www.ncbi.nlm.nih.gov/pubmed/37082704 http://dx.doi.org/10.3389/fped.2023.1132740 |